Adjuvance Technologies Inc.
Roca, NE Doing business as Adjuvance
- UEI
- C6L6GD4QGWG9
- CAGE
- 5NFJ7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 5200 Quarry Ledge Rd, Roca, NE 68430, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Preclinical development of semisynthetic saponin immunological adjuvant titerquil-1055 in the context of an influenza… | National Institute of Allergy and Infectious Diseases | $1,471,319 | |
| Determining the impact of semisynthetic saponin immunologic adjuvant titerquil-1055 on influenza vaccine… | National Institute of Allergy and Infectious Diseases | $223,002 | |
| Large scale synthesis of the next generation synthetic saponin adjuvant titerquil | National Institutes of Health | $225,000 | |
| Large scale synthesis of the next generation synthetic saponin adjuvant titerquil | National Institute of Allergy and Infectious Diseases | $1,499,999 |
Quick answers
What is Adjuvance Technologies Inc.'s UEI?
Adjuvance Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is C6L6GD4QGWG9.
What is Adjuvance Technologies Inc.'s CAGE code?
Adjuvance Technologies Inc.'s CAGE code is 5NFJ7.
What is Adjuvance Technologies Inc.'s primary NAICS code?
Adjuvance Technologies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Adjuvance Technologies Inc. located?
Adjuvance Technologies Inc.'s physical address in SAM.gov is 5200 Quarry Ledge Rd, Roca, NE 68430, USA.
Is Adjuvance Technologies Inc. registered in SAM.gov?
Yes. Adjuvance Technologies Inc.'s SAM.gov registration is active through August 25, 2027.
What is Adjuvance Technologies Inc.'s most recent federal award?
Adjuvance Technologies Inc.'s most recent federal contract award is Preclinical development of semisynthetic saponin immunological adjuvant titerquil-1055 in the context of an influenza… (75N93019C00016), from National Institute of Allergy and Infectious Diseases, on June 16, 2019.
On GovTribe
See Adjuvance Technologies Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors